Prostate Cell News Volume 16.12 | Jul 04 2025

    0
    43







    2025-07-03 | MCN 17.12


    Mammary Cell News by STEMCELL Technologies
    Vol. 17.12 – 3 July, 2025
    TOP STORY

    The Vps13-Like Protein BLTP2 Regulates Phosphatidylethanolamine Levels to Maintain Plasma Membrane Fluidity and Breast Cancer Aggressiveness

    Scientists found that bridge-like lipid transport proteins (BLTPs) facilitate the growth of a TNBC cell line and sustain its aggressiveness in an in vivo model of metastasis, suggesting that maintenance of plasma membrane fluidity by BLTP2 may be critical for tumorigenesis in humans.
    [Nature Cell Biology]

    Full Article
    PUBLICATIONSListed by the impact factor of the journal

    Autophagy-Targeted NBR1-P62/SQSTM1 Complexes Promote Breast Cancer Metastasis by Sequestering ITCH

    Investigators showed that autophagy normally suppresses breast cancer metastasis by enabling the clearance of NBR1–p62/SQSTM1 complexes that instruct p63-mediated pro-metastatic basal differentiation programs.
    [Nature Cell Biology]

    Abstract

    p95HER2, a Truncated Form of the HER2 Oncoprotein, Drives an Immunosuppressive Program in HER2 Breast Cancer that Limits Trastuzumab Deruxtecan Efficacy

    Scientists demonstrated that p95HER2, a truncated form of human epidermal growth factor receptor 2 (HER2), drives immune evasion in HER2-positive female breast cancer, enhancing tumor growth and conferring therapy resistance.
    [Nature Cancer]

    Abstract

    pH-Triggered Delivery of Pirarubicin-Gemcitabine Duo Using Polymeric Nanoparticles for Synergistic Breast Cancer Therapy

    Researchers investigated the development of pirarubicin and gemcitabine co-loaded polymeric nanoparticles for synergistic activity against breast cancer cells.
    [Nanoscale Horizons]

    AbstractGraphical Abstract

    Discovery of Diaryl Piperidone-Sulfonamide As a Novel Dual-Target Inhibitor of STAT3/CAIX Inducing Ferroptosis in Triple-Negative Breast Cancer Cells

    A series of diaryl piperidone-sulfonamide derivatives were designed as dual inhibitors of STAT3/CAIX and ferroptosis inducers for TNBC.
    [Journal of Medicinal Chemistry]

    AbstractGraphical Abstract

    Chimeric Diphtheria Toxin-CCL8 Cytotoxic Peptide for Breast Cancer Management

    The specificity of a chimeric cytotoxic peptide was confirmed in vitro by testing the cytotoxic activity of breast cancer cells overexpressing CCR5, a major CCL8 receptor, and by a neutralizing anti-CCL8 antibody they developed.
    [Molecular Oncology]

    Full Article

    M1 Macrophage Extracellular Vesicles and TLR3 Agonist Nanoparticles Down-Regulate Immunosuppression and Metastasis Via AKT/TAM in Triple-Negative Breast Cancer

    Macrophage type 1-derived extracellular vesicles were isolated and combined with poly(lactic-co-glycolic acid) nanoparticles loaded with the TLR3 agonist poly I:C as a therapeutic strategy to investigate their antitumor activity by downregulating tumor immune escape in the tumor microenvironment of breast cancer.
    [Molecular Carcinogenesis]

    Full Article
    Scientific resources to support your organoids research. Learn More!
    REVIEWS

    Liquid Biopsy in Breast Cancer: Clinical Implications of ctDNA and CTCs in Diagnosis, Treatment, and Monitoring

    The authors focus on the clinical applications of circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) in breast cancer progression, relapse, diagnosis, and treatment response.
    [Molecular and Cellular Biochemistry]

    Abstract
    INDUSTRY AND POLICY NEWS

    Susan G. Komen® Applauds US Supreme Court Decision Protecting No-Cost Access to Lifesaving Breast Care

    Susan G. Komen® commended the United States Supreme Court’s decision to overturn a lower court decision that threatened access to preventive breast care services, including screening mammography, risk-reducing medications for high-risk individuals, and genetic counseling.
    [Susan G. Komen]

    Press Release

    Tim Whelan Appointed to Order of Canada for Treatment-Changing Breast Cancer Research

    The appointment, announced by the Office of the Governor General, recognizes Dr. Whelan’s global impact on radiation oncology, particularly in the treatment of breast cancer.
    [McMaster University]

    Press Release
    FEATURED EVENT

    Hormone-Dependent Cancers

    August 10 – 15, 2025
    Newry, Maine, United States

    > See All Events

    JOB OPPORTUNITIES

    Research Assistant – Multiomics of Breast Milk

    University of Cambridge – Cambridge, England, United Kingdom

    Postdoctoral Position – Biomedical Sciences

    University of Pennsylvania – Philadelphia, Pennsylvania, United States

    Postdoctoral Research Associate – Lung and Mammary Gland

    Princeton University – Princeton, New Jersey, United States

    Professor – Cancer Cell Biology

    University of Southampton – Southampton, England, United Kingdom

    Research Associate – Bioinformatics

    University of Cambridge – Cambridge, England, United Kingdom

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2